Skip to main content
. 2022 Feb 7;32(e2):e145–e152. doi: 10.1136/tobaccocontrol-2021-056901

Table 3.

Abstinence for 12+ months at Wave 5 among smokers who tried to quit prior to Wave 4 according to products used to assist during last quit attempt prior to Wave 4

Product used to assist during last quit attempt prior to W4 W4 sample type Sample size Abstinent* all tobacco (including e-cigarettes) at W5 Abstinent cigarettes, not all tobacco at W5†
Wtd% 95% CI Wtd% 95% CI
E-cigarette Continuing cohort‡ 319 2.5 (0.5 to 4.5) 8.5 (5.1 to 11.8)
Continuing cohort + refreshment sample§ 401 3.5 (1.5 to 5.5) 9.9 (6.6 to 13.2)
Other tobacco product¶ but no e-cigarettes Continuing cohort 58 2.8 (0 to 6.0) 13.5 (1.5 to 25.4)
Continuing cohort + refreshment sample 77 2.5 (0.5 to 4.5) 14.1 (4.4 to 23.9)
No tobacco product or e-cigarettes but any NRT** or pharmaceutical aid†† Continuing cohort 489 13.2 (9.6 to 16.8) 16.2 (12.7 to 19.6)
Continuing cohort + refreshment sample 582 12.5 (9.6 to 15.4) 15.2 (12.3 to 18.1)
No product Continuing cohort 1613 14.7 (11.8 to 17.6) 19.2 (16.3 to 22.1)
Continuing cohort + refreshment sample 1923 13.9 (11.4 to 16.5) 18.6 (16.0 to 21.2)
Total Continuing cohort 2479 12.6 (10.6 to 14.7) 17.1 (15.0 to 19.2)
Continuing cohort + refreshment sample 2983 12.0 (10.2 to 13.8) 16.7 (14.9 to 18.5)

*Abstinence = 12+ months, reported at Wave 5.

†Those abstinent from cigarettes could be using e-cigarettes or other tobacco products.

‡The continuing cohort were W4 respondents who had been surveyed at previous PATH Study waves (W1–W3).

§The W4 continuing cohort + refreshment sample includes all people interviewed for the PATH Study in 2017 (W4). The purpose of the refreshment sample (those first interviewed at W4) was to reset the size of the cohort and reduce the weighting needed to make estimates that were nationally representative of the US population.

¶Other products used by recent former smokers were those from the cigar family (traditional cigars, cigarillos and filtered cigars) and the smokeless family (snus pouches, loose snus, moist snuff, dip, spit and chewing tobacco).

**NRT (nicotine replacement therapy) includes nicotine patch, gum, inhaler, nasal spray, lozenge or pill.

††Pharmaceutical aid includes Chantix, varenicline, Wellbutrin, Zyban or bupropion.

W4, Wave 4; W5, Wave 5; Wtd, weighted US population estimate (W4 single-wave weights).